Medicaid Expansion Boosts Rx Fills 79% For High-Cost Patients – RAND Study
Executive Summary
Diabetics who were previously uninsured boosted their rate of drug use more than individuals with other chronic diseases once they obtained coverage in 2014, study finds.
You may also be interested in...
Medicaid Driving New Retail Scripts – IMS
Medicaid prescriptions jumped 25.4% in the 27 states, plus D.C., that expanded coverage under ACA.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.